Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

MYO1E Gene Focal Segmental Glomerulosclerosis Type 6 (FSGS6) DNA Test in UAE | 2800 AED

Executive Summary & Core Metrics

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation by DHA-Licensed Medical Genetics Consultant.
  • Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.

Test Overview & Methodology

The MYO1E Gene FSGS6 DNA Test utilizes next-generation sequencing (NGS) to analyze the entire coding region, splice sites, and intronic boundaries of the MYO1E gene. This monogenic test is designed to confirm a diagnosis of autosomal recessive focal segmental glomerulosclerosis type 6 (FSGS6) and guide family cascade screening. All procedures follow strict DHA regulations, with results delivered within 3 to 4 weeks following mandatory genetic counselling.

Feature Our Test (NGS Gold Standard) Closest Alternative (Single‑Gene Sanger)
Methodology Full MYO1E gene sequencing by Next Generation Sequencing (NGS) Targeted Sanger sequencing of selected exons
Variant Detection Comprehensive – covers all coding regions, splice sites, and deep intronic mutations Limited to known hotspots; may miss novel or deep intronic variants
Turnaround Time 3–4 weeks 4–6 weeks
Pre‑Test Requirement In‑person genetic counselling and pedigree chart (mandatory) Often optional; less structured consent process
Price (UAE) 2,800 AED 2,500–3,200 AED (variable)

Physician Insight & Safety Protocols

“As a DHA-licensed Consultant in Medical Genetics, I emphasize that the MYO1E gene test is a precise tool for diagnosing monogenic FSGS6. However, results must always be interpreted alongside renal biopsy histology, urinary protein quantification, and detailed family history. A negative result does not exclude all genetic kidney diseases, and a positive finding warrants prompt referral to a nephrologist for disease management and family counselling.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403

Safety & Exclusion Criteria

  • Exclusion: Patients unable to provide informed consent or those requiring emergency dialysis; minors must have legal guardian consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
  • Red Flags: Seek immediate hospital care if you experience sudden severe flank pain, complete cessation of urination, or hypertensive crisis (blood pressure >180/120 mmHg).
  • Pre‑Test Requirement: A mandatory genetic counselling session is conducted to draw a detailed pedigree chart and discuss implications. This is a DHA-mandated step prior to sample collection.

Medication Advisory

Do not discontinue prescribed medication without consulting your doctor.

Patient FAQ & Clinical Guidance

1. What does the MYO1E gene test detect?

This DNA test identifies pathogenic mutations in the MYO1E gene responsible for autosomal recessive focal segmental glomerulosclerosis type 6, helping confirm the diagnosis and guide family screening.

2. How long does it take to receive results?

Results are typically reported within 3 to 4 weeks from sample receipt, including a post‑clinical guidance call from our senior medical team.

3. Is home blood collection available in Dubai and Abu Dhabi?

Yes, our ISO-certified phlebotomy team offers hospital-grade home collection across all emirates from 8 AM to 11 PM, with cold-chain transport ensuring sample integrity.

4. What is the role of genetic counselling before the test?

Genetic counselling is mandatory and includes drawing a three-generation pedigree, discussing inheritance patterns, potential implications for family members, and obtaining informed consent as per UAE medical liability regulations.

5. Can the test be performed on an archival tissue sample?

No – for DNA sequencing, the test requires a fresh peripheral blood sample. Archival specimens are not suitable for this analysis. Secure Medical Courier Solid Tissue Specimen Retrieval is not applicable for this test.

UAE Regulatory & Data Privacy Adherence

Data Protection & Compliance

  • Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): All genetic and clinical data processed in compliance with PDPL provisions for patient consent, data minimization, and secure storage.
  • Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Electronic health records and tele-counselling sessions adhere to ICT security standards.
  • Federal Decree-Law No. 4 of 2016 on Medical Liability: Clinical safety protocols, informed consent, and mandatory genetic counselling are aligned with this law.

Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Facility License: 1143

Clinical & Logistical Metadata

Test Name MYO1E Gene Focal Segmental Glomerulosclerosis Type 6 (FSGS6) DNA Test
Price (AED) 2,800 AED
Turnaround Time 3–4 weeks
Sample Type / Matrix Peripheral whole blood (EDTA tube) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM
Methodology Used Next Generation Sequencing (NGS) – full gene sequencing
ICD-10-CM Code N04.2 (Nephrotic syndrome with focal and segmental glomerular lesions) ; N04.2
LOINC Code 21636-6 (DNA sequencing)
DHA Facility License & Laboratory Address Facility License #1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians